Track topics on Twitter Track topics that are important to you
CHAPEL HILL, N.C., Aug. 3, 2017 /PRNewswire/ -- With the shift in the last decade from a support function to an independent role, Medical Affairs groups in the pharmaceutical industry are now playing a bigger role in companies' patient engagement programs.
As part of its involvement in patient engagement programs, Medical Affairs groups have to be effective at collaborating with both internal and external stakeholders.
To capture current practices on this topic, research and consulting leader Best Practices, LLC conducted a study that examines to what extent Medical Affairs collaborates with different internal and external stakeholders, and which internal and external groups are most important for effective patient engagement programs.
In addition, this new study looks at what patient engagement activities Medical Affairs groups are utilizing along the patient journey – that is from early stage of a disease to late stage. The end of the study includes verbatims from participants about their lessons learned and pitfalls.
The research study examines how and where Medical Affairs leads key aspects of patient engagement programs. For instance, the study presents data on Medical Affairs leaders' current perspective on what patient engagement activities are most important across the key areas of patient health outcomes, patient advocacy group, patient education and patient adherence. The study shows the involvement level of Medical Affairs groups across the different activities within these four key areas of patient engagement.
The report, "Medical Affairs' Role in Patient Engagement Activities," presents reliable industry metrics on key aspects of patient engagement programs, including collaboration, activities, support, and involvement.
Topics addressed in the 88-page study include:
For this study, Best Practices, LLC engaged 39 leaders from 29 biopharmaceutical companies through a benchmarking survey.
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1458.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
SOURCE Best Practices, LLCNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...